Compulsory education reform and child mortality in Peru
Health Economics · 2023
DOI: 10.1002/hec.4696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Economics, 2023. Verfasst von Thao Bui. Beteiligte Einrichtung: Department of Economics, Louisiana State University, Baton Rouge, Louisiana, USA. Hauptthemen laut MEDLINE: Child Mortality, Infant Mortality. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
The government of Peru amended its constitution to increase compulsory education from six to 11 years in 1993. This constitutional amendment provides a natural experiment to investigate the impact of maternal education on child mortality. Exploiting differences in the reform exposure by age, I find that mothers who were exposed to the reform were less likely to experience the death of a child. There is also evidence that the reform caused a decline in infant mortality. These results are not driven by the age difference between mothers who were treated by the reform and those who were not treated. Additional analyses reveal that the reform increased age at first birth, decreased desired fertility, reduced smoking, and improved economic opportunities for women. The results demonstrate that compulsory schooling may be a useful policy tool to improve women's education, which can, in turn, enhance the survival of their children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Economics, Louisiana State University, Baton Rouge, Louisiana, USA.
ORCID-Profile: Thao Bui
Zitieren
APA
Bui, T. (2023). Compulsory education reform and child mortality in Peru. Health Economics. https://doi.org/10.1002/hec.4696
Vancouver
Bui T. Compulsory education reform and child mortality in Peru. Health Economics. 2023. doi:10.1002/hec.4696
BibTeX
@article{Bui2023,
author = {Bui, Thao},
title = {Compulsory education reform and child mortality in Peru},
journal = {Health Economics},
year = {2023},
doi = {10.1002/hec.4696}
}
EUVIMED